Lung Research Florida

Research Facility of Advanced Asthma Clinic | Broward Pulmonary & Sleep Specialists

General Line: 954-522-7226 x1
Research Referrals: 954-520-7296 x1

Refer Your Patients to Cutting-Edge Respiratory Research

Partner with Dr. Frank Hull and our research team to provide your patients access to breakthrough treatments while advancing pulmonary medicine. Easy referral process with comprehensive collaboration.

🏥 Maintain Collaborative Care
📋 Comprehensive Reporting
⚡ Streamlined Process
Make a Referral View Current Studies
Clinical research collaboration

Simple 3-Step Referral Process

Your patients can access innovative treatments while you maintain collaborative care throughout their participation

1

Identify & Refer

Review patient criteria and submit referral via phone, fax, or our online form. Initial screening takes place within 24 hours.

2

Patient Evaluation

Our team conducts comprehensive evaluation and discusses study options with your patient. You receive detailed screening results.

3

Ongoing Collaboration

Regular progress reports keep you informed. Patient continues routine care with you while participating in the research study.

Current Research Studies

Overview of active clinical trials with patient criteria and study objectives

Advanced Biologic Therapy for Severe Asthma

Actively Enrolling

Study Objective

Evaluate efficacy and safety of a novel dual-pathway biologic targeting IL-4/IL-13 and IL-5 pathways in patients with severe, uncontrolled asthma despite high-dose inhaled corticosteroids plus additional controller.

Key Inclusion Criteria

  • Ages 18-75 years
  • Physician-diagnosed asthma for ≥12 months
  • High-dose ICS + additional controller for ≥3 months
  • ≥2 exacerbations in past 12 months requiring systemic corticosteroids
  • Blood eosinophils ≥150 cells/μL OR FeNO ≥25 ppb
  • ACQ-6 score ≥1.5

Patient Benefits

  • Free investigational biologic therapy
  • Comprehensive pulmonary function monitoring
  • Study-related care at no cost
  • Monetary compensation for participation

COPD Cardiovascular Protection Study

Actively Enrolling

Study Objective

Investigate whether optimized COPD treatment with advanced triple combination therapy reduces major adverse cardiovascular events (MACE) compared to standard dual therapy.

Key Inclusion Criteria

  • Ages 40-80 years
  • COPD diagnosis confirmed by spirometry
  • Smoking history ≥10 pack-years
  • Established cardiovascular disease OR high CV risk
  • ≥1 moderate/severe COPD exacerbation in past year
  • Currently on dual bronchodilator therapy

Patient Benefits

  • Free advanced COPD medication
  • Comprehensive cardiovascular monitoring
  • Regular specialist pulmonary care
  • Study-related procedures at no cost

Chronic Cough Neurological Treatment

Actively Enrolling

Study Objective

Assess efficacy and safety of P2X3 receptor antagonist in patients with refractory chronic cough that has persisted despite standard treatments.

Key Inclusion Criteria

  • Ages 18-80 years
  • Chronic cough ≥1 year duration
  • Cough severity VAS ≥40mm
  • Failed standard treatments (ACE inhibitors, PPIs, antihistamines)
  • No acute respiratory illness within 4 weeks
  • Negative chest imaging within 2 years

Patient Benefits

  • Access to innovative neurological treatment
  • Validated cough assessment tools
  • Quality of life measurements
  • Compensation for time and travel

Non-CF Bronchiectasis Treatment

Actively Enrolling

Study Objective

Evaluate novel anti-inflammatory approach to reduce exacerbations and improve quality of life in patients with non-cystic fibrosis bronchiectasis.

Key Inclusion Criteria

  • Ages 18-85 years
  • CT-confirmed bronchiectasis
  • ≥2 moderate OR ≥1 severe exacerbation in past year
  • Clinically stable for ≥4 weeks
  • Negative cystic fibrosis screening
  • Chronic sputum production

Patient Benefits

  • Investigational anti-inflammatory treatment
  • Reduced need for rescue antibiotics
  • Comprehensive respiratory monitoring
  • Study medication at no cost

Submit a Patient Referral

Complete this form to refer a patient, or call our dedicated research referral line at 954-520-7296 x1

Referring Physician Information

Patient Information

Clinical Information

Preferred Contact Method

Our research coordinators will contact you within 24 hours to discuss the referral.

Why Choose Our Research Program?

Collaborative partnerships that benefit both physicians and patients

🤝

Collaborative Care Model

Your patients continue their routine care with you while participating in our studies. We provide comprehensive progress reports and maintain open communication throughout.

📊

Detailed Reporting

Receive comprehensive screening results, progress updates, and study outcomes. Access to advanced diagnostic data that may benefit ongoing patient care.

🏆

Leading Research Team

Dr. Hull's 20+ years of clinical research experience and numerous published studies ensure the highest standards of patient care and scientific rigor.

⚡

Rapid Response

24-hour response to referrals, expedited screening process, and prompt communication about patient eligibility and enrollment status.

💊

Access to Innovation

Your patients gain access to cutting-edge treatments 3-5 years before they become commercially available, potentially improving their quality of life immediately.

📍

Convenient Location

Centrally located in Plantation with easy access from throughout Broward County. Transportation assistance available for qualifying patients.

Ready to Make a Referral?

Our research coordinators are standing by to discuss patient eligibility and study options. We make the referral process as simple as possible.

Research Referral Line

954-520-7296 x1

Direct line to our research coordinators

Research Referral Fax

954-523-8569

24-hour secure fax line

Email Referrals

Secure email communications

Office Location

Advanced Asthma Clinic - Broward Pulmonary and Sleep Specialists
10059 NW 1st Court
Plantation, FL 33324

Research Coordinator Hours:
Monday - Friday: 8:00 AM - 6:00 PM

Get Directions